Investigational Drug Information for Bitopertin
✉ Email this page to a colleague
What is the drug development status for Bitopertin?
Bitopertin is an investigational drug.
There have been 13 clinical trials for Bitopertin.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, Protoporphyria, Erythropoietic, and beta-Thalassemia. The leading clinical trial sponsors are Hoffmann-La Roche, Disc Medicine, Inc, and Karolinska Institutet.
Summary for Bitopertin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 134 |
| WIPO Patent Applications | 76 |
| Japanese Patent Applications | 28 |
| Clinical Trial Progress | Phase 3 (2010-11-01) |
| Vendors | 60 |
Recent Clinical Trials for Bitopertin
| Title | Sponsor | Phase |
|---|---|---|
| Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP | Disc Medicine, Inc | Phase 2/Phase 3 |
| A Phase I/II, Intra-Patient Dose-Escalation Study of the Selective GlyT1 Inhibitor, Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia. | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1/Phase 2 |
| Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP | Disc Medicine, Inc | Phase 2 |
Clinical Trial Summary for Bitopertin
Top disease conditions for Bitopertin
Top clinical trial sponsors for Bitopertin
US Patents for Bitopertin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
